Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have not taken most types of prescription medications (such as heart medications, anti-seizure medications, antipsychotics, insulin, chemotherapy, or immunosuppressants) in the past 14 days
- People who take certain medications (such as short-acting benzodiazepines, asthma inhalers, steroids, or medical marijuana) fewer than 7 out of the past 14 days may still be considered
- People who take longer-acting benzodiazepines or sleep medications, as long as those medications were not taken within 48 hours of the brain scan
- People who take no more than two non-insulin diabetes medications on a regular basis
- People who stopped taking a disallowed medication at least one month ago and meet all other criteria
Who may not be able to join:
- People who have had 35 or more alcoholic drinks in the past 7 days, or who have had 6 or more drinks on 3 or more separate occasions in the past 7 days
- People who have used illegal drugs on 7 or more days in the past 2 weeks
- People with epilepsy or a history of seizures
- People with a history of heart attack, stroke, bypass surgery, angioplasty, heart failure, or irregular heart rhythm
- People with very high blood pressure (above 160 systolic and/or above 100 diastolic)
- People who have received cancer treatment in the past 12 months (except for non-melanoma skin cancer)
- People with liver disease or kidney disease
- People with Type 1 diabetes
- People with a history of a major neurological condition or brain injury that still causes ongoing symptoms or thinking difficulties (such as multiple sclerosis, cerebral palsy, or a serious head injury)
- People with a history of schizophrenia or bipolar disorder
- People with a lung disease that requires ongoing drug treatment (though occasional use of asthma or allergy inhalers is not automatically disqualifying)
- People who are pregnant or planning to become pregnant in the next 3 months
- People with a visual impairment that would prevent them from reading printed or on-screen text
- People with colour blindness that may affect their ability to distinguish colours on study tasks
- People who are not comfortable in confined spaces and would not be comfortable in an MRI scanner (a mock MRI trial run may be offered to help people decide)
- People who have non-removable metal implants, devices, or objects in or on the body that are not compatible with MRI (compatibility of medical devices may be assessed with documentation from a medical professional)
- People who are taller than 7 feet 2 inches or weigh more than 350 pounds, as they may not fit in the MRI scanner
- People who frequently work night shifts (where half or more of a full workday falls between midnight and 8am, occurring more than 12 times in the past year)
- People who have undergone brain stimulation procedures (such as TMS, tDCS, vagus nerve stimulation, or transcranial ultrasound) as part of research or treatment in the past month
- People with a lifetime history of a suicide attempt, or who have experienced suicidal thoughts within the past year
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thomas E Kraynak, PhD, University of Pittsburgh
Phone: 412-246-6361
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dorsal anterior cingulate cortex activation to stress; Dorsal anterior cingulate cortex connectivity to stress; Change in arousal during stress; Change in valence during stress; Change in perceived control during stress; Systolic blood pressure response to stress; Heart rate response to stress
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.